Recent FGEN News
- FibroGen to Report Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/04/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 08:12:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 12:00:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 12:00:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 12:00:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:11:01 PM
- FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/07/2024 09:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 09:05:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:05:13 PM
- FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 08:18:48 PM
- FibroGen to Report Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/30/2024 08:07:00 PM
- FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update • GlobeNewswire Inc. • 07/30/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/11/2024 04:15:03 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/08/2024 08:32:42 PM
- FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024 • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:30:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 10:37:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:00:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:12:34 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM